ReviewCancers2023

The Development and Role of Capmatinib in the Treatment of MET-Dysregulated Non-Small Cell Lung Cancer-A Narrative Review.

Robert Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.